|
Market Research Report
Global Skin Cancer Therapeutics Markets
| Published by |
Frost & Sullivan |
| Published |
October, 2009 |
Product code |
102289 |
| Content info |
|
| Price |
|
|
Global Skin Cancer Therapeutics Markets published by Frost & Sullivan in October, 2009. This report price starts from US $ 6500.
Abstract
This research service analyses the global skin cancer therapeutics market. It
analyses market drivers, restraints and challenges faced by industry
participants. Revenue forecasts and pipeline analysis has been discussed. It
also provides strategic recommendations.
Table of Contents
1. Executive Summary
Overview
- Overview of the Global Skin Cancer Therapeutics Markets
2. Glossary of Terms
List of Terms
3. Research Methodology
Research Objectives and Scope
- Methodology
- Assumptions and Limitations
- Objective
- Segment Scope
- Geographical Scope
4. Skin Cancer Overview
Introduction
- Disease Characteristics
- Epidemiology
- Risk Factors
- Diagnosis
- Staging & Prognosis
- Major Sub-types
Patient Forecasts
- Patient Forecasts of Skin Cancer in the World
- Patient Forecasts of Skin Cancer in the U.S
- Patient Forecasts of Skin Cancer in the European Union
- Patient Forecasts of Skin Cancer in Australia
5. Industry Challenges
Industry Challenges for the Global Skin Cancer Therapeutics Market
6. Current Treatment Options in the Global Skin Cancer Market
Current Therapies
- Analysis of Key Current Therapies
7. Key Trends in the Global Skin Cancer Therapeutics Market
Analysis of Key Global Trends in the Skin Cancer Therapeutics Market
8. Market Engineering Research of the Global Skin Cancer Therapeutics Market
Analysis of the Global Skin Cancer Therapeutics Market
- Market Drivers
- Market Restraints
9. Geographical Analysis of the Melanoma Therapeutics Market
Global Melanoma Market
- Global Melanoma Therapeutics Market Overview
- Market Engineering Measurements
- Revenue Forecasts of the Global Melanoma Therapeutics Market
U.S Melanoma Market
- U.S. Melanoma Therapeutics Market Overview
- Market Engineering Measurements
- Revenue Forecasts of the U.S. Melanoma Therapeutics Market
European Union Melanoma Market
- European Union Melanoma Therapeutics Market Overview
- Market Engineering Measurements
- Revenue Forecasts of the European Union Melanoma Therapeutics Market
Rest-of-World Melanoma Market
- Rest-of-World Melanoma Therapeutics Market Overview
- Market Engineering Measurements
- Revenue Forecasts of the Rest-of-World Melanoma Therapeutics Market
10. Emerging Treatment Options in the Global Skin Cancer Market
Pipeline Analysis
- Emerging Treatment Options and Pipeline Analysis
11. Strategic Recommendations for the Global Skin Cancer Therapeutics Market
Market Engineering Recommendations
- Strategic Recommendations
12. Decision Support Databases
Databases for Analysis
- Cancer Cases
- Government Healthcare Expenditure
- Private Healthcare Expenditure
- Per Capita Healthcare Expenditure
- Per cent Healthcare Expenditure in GDP
- Total Healthcare Expenditure
- Pharmaceutical Market
- Pharmaceutical R&D Expenditure
- Pharmaceutical R&D Expenditure as a Percentage of Pharmaceutical Market
- Number of Biotechnology Companies
- Venture Capital Investment in Biotech R & D
- Government R&D Investment in Biotechnology
- Per cent of Government Investment in Biotechnology R&D
- Population 65 Plus
- Per cent Population 65 Plus
|
